Skip to main content
Clinical Trials/NCT05588232
NCT05588232CompletedNot Applicable

Prospective Randomized Comparative Study Evaluating the Efficacy of Therapeutic Virtual Reality Versus Pharmacological Sedation on Pain and Anxiety During Interventional Cardiology Procedures

Elsan2 sites in 1 country136 target enrollmentStarted: October 18, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
136
Locations
2
Primary Endpoint
Maximum pain during the interventional cardiology procedures

Study Overview

Brief Summary

Immersion sedation in virtual reality could be an alternative to conventional pharmacological sedation, during interventional cardiology acts on pain and anxiety control.

The objective of this study is to determine whether virtual reality immersion is non-inferior to drug sedation on pain and anxiety, during coronary angiography or angioplasty.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patient
  • who must benefit from one of the following scheduled interventional cardiology outpatient procedures: coronary angiography, coronary angioplasty, peripheral angioplasty (lower limbs)
  • Affiliation to a social security scheme or beneficiary of such a scheme.
  • Patient having signed the free and informed consent

Exclusion Criteria

  • Language barrier
  • Claustrophobia
  • History of intolerance to Virtual Reality
  • Patient with epilepsy
  • Refusal to participate in the study
  • Protected patient: minor, adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding or parturient woman
  • Unstable patient (state of shock, respiratory or neurological distress)

Outcomes

Primary Outcomes

Maximum pain during the interventional cardiology procedures

Time Frame: 1 day

measured on a scale of 0 to 10.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Elsan
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

the Effectiveness of Therapeutic Virtual... | Clinical Trial